Faculty of Radiological Technology

tadokoro masanori

  (田所 匡典)

Profile Information

Affiliation
School of Health Sciences, Faculty of Radiological Technology, Fujita Health University
Degree
博士(医学)

J-GLOBAL ID
201501006264562095
researchmap Member ID
7000013035

Misc.

 59
  • 白川誠二, 後田智也, 橋本洋志, 田所匡典, 宇野正樹, 辻本正和, 石黒雅伸, 外山宏
    核医学技術, 33(4) 367-376, Oct, 2013  
  • 太田 誠一朗, 外山 宏, 宇野 正樹, 加藤 正基, 石黒 雅伸, 夏目 貴弘, 伊藤 文隆, 菊川 薫, 田所 匡典, 市原 隆, 片田 和広
    核医学, 48(2) 101-107, May, 2011  Peer-reviewed
  • Yasushi Tachi, Shingo Iwano, Katsuhiko Kato, Masanori Tadokoro, Shinji Naganawa
    Clinical Nuclear Medicine, 33(12) 845-851, Dec, 2008  Peer-reviewed
    RATIONALE: Radioiodine therapy improves the survival of patients with pulmonary metastases of differentiated thyroid cancer (DTC). It is controversial whether the diagnostic whole-body I-131 scan (DWS) before therapy is essential. We determined whether DWS could predict the efficacy of I-131 therapy for pulmonary metastases. METHODS: We undertook a retrospective review of records of 42 patients (28 women and 14 men, mean age 52.7 years). The patients had received 62 rounds of I-131 therapy for lung metastases of DTC at our institution between June 2002 and June 2006. On the same day that the DWS (dose of 185 MBq) (5 mCi) was completed, the patient received I-131 therapy (dose of 3700-7400 MBq) (100-200 mCi). Post-therapy whole-body scans (PWS) were performed after 3 to 4 days and 7 to 8 days. For all therapies, chest CT images were obtained before I-131 therapy, and 3 and 6 months after therapy for evaluation of therapeutic effectiveness. In addition, serum thyroglobulin (Tg) values were measured before and after the radioiodine therapy for all treatments. RESULTS: In the group demonstrating I-131 accumulation for pulmonary metastases on DWS, 72% of patients showed a reduction of pulmonary metastases on follow-up CT. On the other hand, in the group that failed to accumulate I-131 on DWS, only 5% of patients showed a reduction of pulmonary metastases. After therapy, serum Tg levels decreased significantly in the group that initially showed accumulation of I-131 in DWS (P = 0.045). In contrast, no remarkable changes between pre- and post-therapy Tg levels were observed in patients who failed to accumulate I-131 in DWS. CONCLUSION: A whole-body I-131 diagnostic scan before I-131 therapy has a predictive value for the efficacy of therapeutic radioiodine treatment for pulmonary metastases of differentiated thyroid cancer. © 2008 by Lippincott Williams &amp Wilkins.
  • 田所匡典
    健康文化振興財団紀要, (43) 93-104, Nov, 2008  
  • Ito S, Kato K, Ikeda M, Iwano S, Makino N, Tadokoro M, Abe S, Nakano S, Nishino M, Ishigaki T, Naganawa S
    J Nucl Med, 48(6) 889-895, Jun, 2007  Peer-reviewed

Books and Other Publications

 3

Presentations

 6